BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Z, Zhang H, Xu S, Liu Z, Cheng Q. The adaptive transition of glioblastoma stem cells and its implications on treatments. Signal Transduct Target Ther 2021;6:124. [PMID: 33753720 DOI: 10.1038/s41392-021-00491-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Parsaei H, Moosavifar MJ, Eftekharzadeh M, Ramezani R, Barati M, Mirzaei S, Nobakht M. Exosomes to control glioblastoma multiforme: Investigating the effects of mesenchymal stem cell-derived exosomes on C6 cells in vitro. Cell Biol Int 2022. [PMID: 36098338 DOI: 10.1002/cbin.11884] [Reference Citation Analysis]
2 Chen B, Zhou X, Yang L, Zhou H, Meng M, Wu H, Liu Z, Zhang L, Li C. Glioma stem cell signature predicts the prognosis and the response to tumor treating fields treatment. CNS Neurosci Ther 2022. [PMID: 36070228 DOI: 10.1111/cns.13956] [Reference Citation Analysis]
3 Montella L, Del Gaudio N, Bove G, Cuomo M, Buonaiuto M, Costabile D, Visconti R, Facchini G, Altucci L, Chiariotti L, Della Monica R. Looking Beyond the Glioblastoma Mask: Is Genomics the Right Path? Front Oncol 2022;12:926967. [PMID: 35875139 DOI: 10.3389/fonc.2022.926967] [Reference Citation Analysis]
4 Mahinfar P, Mansoori B, Rostamzadeh D, Baradaran B, Cho WC, Mansoori B. The Role of microRNAs in Multidrug Resistance of Glioblastoma. Cancers 2022;14:3217. [DOI: 10.3390/cancers14133217] [Reference Citation Analysis]
5 Poonaki E, Nickel AC, Shafiee Ardestani M, Rademacher L, Kaul M, Apartsin E, Meuth SG, Gorji A, Janiak C, Kahlert UD. CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells. Int J Mol Sci 2022;23:5479. [PMID: 35628289 DOI: 10.3390/ijms23105479] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Xu J, Gao Z, Liu K, Fan Y, Zhang Z, Xue H, Guo X, Zhang P, Deng L, Wang S, Wang H, Wang Q, Zhao R, Li G. The Non-N6-Methyladenosine Epitranscriptome Patterns and Characteristics of Tumor Microenvironment Infiltration and Mesenchymal Transition in Glioblastoma. Front Immunol 2021;12:809808. [PMID: 35154083 DOI: 10.3389/fimmu.2021.809808] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Wang Z, Mo Y, Tan Y, Wen Z, Dai Z, Zhang H, Zhang X, Feng S, Liang X, Song T, Cheng Q. The ALDH Family Contributes to Immunocyte Infiltration, Proliferation and Epithelial-Mesenchymal Transformation in Glioma. Front Immunol 2021;12:756606. [PMID: 35116021 DOI: 10.3389/fimmu.2021.756606] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Crivii CB, Boșca AB, Melincovici CS, Constantin AM, Mărginean M, Dronca E, Suflețel R, Gonciar D, Bungărdean M, Șovrea A. Glioblastoma Microenvironment and Cellular Interactions. Cancers (Basel) 2022;14:1092. [PMID: 35205842 DOI: 10.3390/cancers14041092] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Srinivasan ES, Deshpande K, Neman J, Winkler F, Khasraw M. The microenvironment of brain metastases from solid tumors. Neurooncol Adv 2021;3:v121-32. [PMID: 34859239 DOI: 10.1093/noajnl/vdab121] [Reference Citation Analysis]
10 Koch K, Hartmann R, Suwala AK, Rios DH, Kamp MA, Sabel M, Steiger HJ, Willbold D, Sharma A, Kahlert UD, Maciaczyk J. Overexpression of Cystine/Glutamate Antiporter xCT Correlates with Nutrient Flexibility and ZEB1 Expression in Highly Clonogenic Glioblastoma Stem-like Cells (GSCs). Cancers (Basel) 2021;13:6001. [PMID: 34885110 DOI: 10.3390/cancers13236001] [Reference Citation Analysis]
11 Xu S, Li X, Tang L, Liu Z, Yang K, Cheng Q. CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas. Front Mol Biosci 2021;8:706949. [PMID: 34540893 DOI: 10.3389/fmolb.2021.706949] [Reference Citation Analysis]
12 Liu H, Pan W, Tang C, Tang Y, Wu H, Yoshimura A, Deng Y, He N, Li S. The methods and advances of adaptive immune receptors repertoire sequencing. Theranostics 2021;11:8945-63. [PMID: 34522220 DOI: 10.7150/thno.61390] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
13 Urbantat RM, Vajkoczy P, Brandenburg S. Advances in Chemokine Signaling Pathways as Therapeutic Targets in Glioblastoma. Cancers (Basel) 2021;13:2983. [PMID: 34203660 DOI: 10.3390/cancers13122983] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Paolillo M, Comincini S, Schinelli S. In Vitro Glioblastoma Models: A Journey into the Third Dimension. Cancers (Basel) 2021;13:2449. [PMID: 34070023 DOI: 10.3390/cancers13102449] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]